157 related articles for article (PubMed ID: 25886454)
1. DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors.
Bambury RM; Bhatt AS; Riester M; Pedamallu CS; Duke F; Bellmunt J; Stack EC; Werner L; Park R; Iyer G; Loda M; Kantoff PW; Michor F; Meyerson M; Rosenberg JE
BMC Cancer; 2015 Apr; 15():242. PubMed ID: 25886454
[TBL] [Abstract][Full Text] [Related]
2. HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts.
Eriksson P; Sjödahl G; Chebil G; Liedberg F; Höglund M
Oncotarget; 2017 Jul; 8(30):48905-48914. PubMed ID: 28388586
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic analysis of primary tumors and metastases in breast cancer.
Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinoma.
Keck B; Ellmann C; Stoehr R; Weigelt K; Goebell PJ; Kunath F; Taubert H; Hartmann A; Wullich B; Wach S
Urol Oncol; 2014 Nov; 32(8):1234-9. PubMed ID: 25087089
[TBL] [Abstract][Full Text] [Related]
5. Canine urothelial carcinoma: genomically aberrant and comparatively relevant.
Shapiro SG; Raghunath S; Williams C; Motsinger-Reif AA; Cullen JM; Liu T; Albertson D; Ruvolo M; Bergstrom Lucas A; Jin J; Knapp DW; Schiffman JD; Breen M
Chromosome Res; 2015 Jun; 23(2):311-31. PubMed ID: 25783786
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
Nickerson ML; Witte N; Im KM; Turan S; Owens C; Misner K; Tsang SX; Cai Z; Wu S; Dean M; Costello JC; Theodorescu D
Oncogene; 2017 Jan; 36(1):35-46. PubMed ID: 27270441
[TBL] [Abstract][Full Text] [Related]
7. Identification of ALK gene alterations in urothelial carcinoma.
Bellmunt J; Selvarajah S; Rodig S; Salido M; de Muga S; Costa I; Bellosillo B; Werner L; Mullane S; Fay AP; O'Brien R; Barretina J; Minoche AE; Signoretti S; Montagut C; Himmelbauer H; Berman DM; Kantoff P; Choueiri TK; Rosenberg JE
PLoS One; 2014; 9(8):e103325. PubMed ID: 25083769
[TBL] [Abstract][Full Text] [Related]
8. Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.
Chekaluk Y; Wu CL; Rosenberg J; Riester M; Dai Q; Lin S; Guo Y; McDougal WS; Kwiatkowski DJ
PLoS One; 2013; 8(4):e60927. PubMed ID: 23593348
[TBL] [Abstract][Full Text] [Related]
9. Centrosome amplification as a putative prognostic biomarker for the classification of urothelial carcinomas.
Yamamoto Y; Misumi T; Eguchi S; Chochi Y; Kitahara S; Nakao M; Nagao K; Hara T; Sakano S; Furuya T; Oga A; Kawauchi S; Sasaki K; Matsuyama H
Hum Pathol; 2011 Dec; 42(12):1923-30. PubMed ID: 21683985
[TBL] [Abstract][Full Text] [Related]
10. Genomic landscape of pancreatic neuroendocrine tumors.
Gebauer N; Schmidt-Werthern C; Bernard V; Feller AC; Keck T; Begum N; Rades D; Lehnert H; Brabant G; Thorns C
World J Gastroenterol; 2014 Dec; 20(46):17498-506. PubMed ID: 25516664
[TBL] [Abstract][Full Text] [Related]
11. Copy number profiles of paired primary and metastatic colorectal cancers.
Kawamata F; Patch AM; Nones K; Bond C; McKeone D; Pearson SA; Homma S; Liu C; Fennell L; Dumenil T; Hartel G; Kobayasi N; Yokoo H; Fukai M; Nishihara H; Kamiyama T; Burge ME; Karapetis CS; Taketomi A; Leggett B; Waddell N; Whitehall V
Oncotarget; 2018 Jan; 9(3):3394-3405. PubMed ID: 29423054
[TBL] [Abstract][Full Text] [Related]
12. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
[TBL] [Abstract][Full Text] [Related]
13. Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy.
McDaniel AS; Hovelson DH; Cani AK; Liu CJ; Zhai Y; Zhang Y; Weizer AZ; Mehra R; Feng FY; Alva AS; Morgan TM; Montgomery JS; Siddiqui J; Sadis S; Bandla S; Williams PD; Cho KR; Rhodes DR; Tomlins SA
Cancer Res; 2015 Dec; 75(24):5219-27. PubMed ID: 26670561
[TBL] [Abstract][Full Text] [Related]
14. Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study.
Ross JS; Gay LM; Nozad S; Wang K; Ali SM; Boguniewicz A; Khaira D; Johnson A; Elvin JA; Vergilio JA; Suh J; Miller VA; Stephens PJ
Breast Cancer Res Treat; 2016 Jan; 155(2):405-13. PubMed ID: 26762307
[TBL] [Abstract][Full Text] [Related]
15. Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma.
Weilandt M; Koch A; Rieder H; Deenen R; Schwender H; Niegisch G; Schulz WA
Cancer Genomics Proteomics; 2014; 11(3):141-53. PubMed ID: 24969694
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.
Riester M; Werner L; Bellmunt J; Selvarajah S; Guancial EA; Weir BA; Stack EC; Park RS; O'Brien R; Schutz FA; Choueiri TK; Signoretti S; Lloreta J; Marchionni L; Gallardo E; Rojo F; Garcia DI; Chekaluk Y; Kwiatkowski DJ; Bochner BH; Hahn WC; Ligon AH; Barletta JA; Loda M; Berman DM; Kantoff PW; Michor F; Rosenberg JE
Clin Cancer Res; 2014 Apr; 20(7):1873-83. PubMed ID: 24486590
[TBL] [Abstract][Full Text] [Related]
17. A systematic comparison of copy number alterations in four types of female cancer.
Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
[TBL] [Abstract][Full Text] [Related]
18. Multiomics approach showing genome-wide copy number alterations and differential gene expression in different types of North-Indian pediatric brain tumors.
Singh N; Sahu DK; Mishra A; Agarwal P; Goel MM; Chandra A; Singh SK; Srivastava C; Ojha BK; Gupta DK; Kant R
Gene; 2016 Feb; 576(2 Pt 2):734-42. PubMed ID: 26456192
[TBL] [Abstract][Full Text] [Related]
19. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
[TBL] [Abstract][Full Text] [Related]
20. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
